These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Importance of Lassa Fever and Its Disease Management in West Africa. Reyna RA; Littlefield KE; Shehu N; Makishima T; Maruyama J; Paessler S Viruses; 2024 Feb; 16(2):. PubMed ID: 38400041 [TBL] [Abstract][Full Text] [Related]
7. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues. Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220 [TBL] [Abstract][Full Text] [Related]
8. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol. Penfold S; Adegnika AA; Asogun D; Ayodeji O; Azuogu BN; Fischer WA; Garry RF; Grant DS; Happi C; N'Faly M; Olayinka A; Samuels R; Sibley J; Wohl DA; Accrombessi M; Adetifa I; Annibaldis G; Camacho A; Dan-Nwafor C; Deha ARE; DeMarco J; Duraffour S; Goba A; Grais R; Günther S; Honvou ÉJJP; Ihekweazu C; Jacobsen C; Kanneh L; Momoh M; Ndiaye A; Nsaibirni R; Okogbenin S; Ochu C; Ogbaini E; Logbo ÉPMA; Sandi JD; Schieffelin JS; Verstraeten T; Vielle NJ; Yadouleton A; Yovo EK; PLoS One; 2023; 18(3):e0283643. PubMed ID: 36996258 [TBL] [Abstract][Full Text] [Related]
9. Current research for a vaccine against Lassa hemorrhagic fever virus. Warner BM; Safronetz D; Stein DR Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299 [TBL] [Abstract][Full Text] [Related]
10. Lassa Fever Induced Hearing Loss: The Neglected Disability of Hemorrhagic Fever. Ficenec SC; Percak J; Arguello S; Bays A; Goba A; Gbakie M; Shaffer JG; Emmett SD; Schieffelin JS; Bausch D Int J Infect Dis; 2020 Nov; 100():82-87. PubMed ID: 32795603 [TBL] [Abstract][Full Text] [Related]
11. The search for animal models for Lassa fever vaccine development. Lukashevich IS Expert Rev Vaccines; 2013 Jan; 12(1):71-86. PubMed ID: 23256740 [TBL] [Abstract][Full Text] [Related]
12. Hearing loss in outbred Hartley guinea pigs experimentally infected with Pichinde virus as a surrogate model of human mammarenaviral hemorrhagic fevers. Brisse M; Fernández-Alarcón C; Huang Q; Kirk N; Schleiss MR; Liang Y; Ly H Virulence; 2022 Dec; 13(1):1049-1061. PubMed ID: 35758052 [TBL] [Abstract][Full Text] [Related]
14. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF Virol J; 2011 Aug; 8():404. PubMed ID: 21843352 [TBL] [Abstract][Full Text] [Related]
15. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF Virol J; 2011 Oct; 8():478. PubMed ID: 22023795 [TBL] [Abstract][Full Text] [Related]
16. Lassa virus antigen distribution and inflammation in the ear of infected strain 13/N Guinea pigs. Huynh T; Gary JM; Welch SR; Coleman-McCray J; Harmon JR; Kainulainen MH; Bollweg BC; Ritter JM; Shieh WJ; Nichol ST; Zaki SR; Spiropoulou CF; Spengler JR Antiviral Res; 2020 Nov; 183():104928. PubMed ID: 32898586 [TBL] [Abstract][Full Text] [Related]
17. Delayed-onset paraparesis in Lassa fever: A case report. Duvignaud A; Doutchi M; Abejegah C; Etafo I; Jaspard M; Serra B; Tricaud E; Levy-Marchal C; Anglaret X; Ahmed LA; Adedosu AN; Malvy D; Ayodeji OO Int J Infect Dis; 2020 Mar; 92():49-52. PubMed ID: 31866549 [TBL] [Abstract][Full Text] [Related]
18. Advanced vaccine candidates for Lassa fever. Lukashevich IS Viruses; 2012 Oct; 4(11):2514-57. PubMed ID: 23202493 [TBL] [Abstract][Full Text] [Related]
19. The niche of One Health approaches in Lassa fever surveillance and control. Arruda LB; Haider N; Olayemi A; Simons D; Ehichioya D; Yinka-Ogunleye A; Ansumana R; Thomason MJ; Asogun D; Ihekweazu C; Fichet-Calvet E; Kock RA Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):29. PubMed ID: 33894784 [TBL] [Abstract][Full Text] [Related]